First Tracks Biotherapeutics grants equity to director
First Tracks Biotherapeutics director Rita Jain received new equity awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4/A
Rhea-AI Filing Summary
First Tracks Biotherapeutics director Rita Jain received new equity awards. On May 12, 2026, she was granted options for 7,000 shares of common stock at an exercise price of $17.81 per share, vesting monthly over one year starting June 12, 2026. She also received 2,500 restricted stock units, each convertible into one share of common stock, which vest in full on the date of the company’s 2027 annual meeting of shareholders, in both cases contingent on continued service.
Insider Trade Summary
Grant/Award: 9,500 shares
Grant/Award
2 txns
Insider
Jain Rita
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 2,500 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 7,000 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 2,500 contracts (Direct);
Stock Option (right to buy) — 7,000 contracts (Direct)
Footnotes (3)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- F2. The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- F3. The stock option vests as to 1/12 of the total shares monthly commencing on June 12, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Key Figures
Stock options granted: 7,000 shares
Option exercise price: $17.81 per share
Option expiration: May 11, 2036
+3 more
6 metrics
Stock options granted
7,000 shares
Stock Option grant to director on May 12, 2026
Option exercise price
$17.81 per share
Exercise price for 7,000 stock options
Option expiration
May 11, 2036
Expiration date of director stock options
RSUs granted
2,500 units
Restricted Stock Unit grant to director on May 12, 2026
RSU vesting date
2027 annual meeting
RSUs vest 100% on 2027 shareholder meeting date
Option vesting start
June 12, 2026
Monthly vesting of 1/12 of 7,000 options
Key Terms
Restricted Stock Unit, RSU, Stock Option, vests
4 terms
Restricted Stock Unit financial
"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
RSU financial
"Each restricted stock unit ("RSU") represents a contingent right to receive 1 share"
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
Stock Option financial
"The stock option vests as to 1/12 of the total shares monthly"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vests financial
"The stock option vests as to 1/12 of the total shares monthly"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did TRAX director Rita Jain report on this Form 4/A?
Rita Jain reported receiving equity awards, not open-market trades. She was granted stock options for 7,000 shares at a $17.81 exercise price and 2,500 restricted stock units, all tied to her service as a director.
How many stock options did Rita Jain receive from First Tracks Biotherapeutics (TRAX)?
She received options covering 7,000 shares of common stock. These options have an exercise price of $17.81 per share and vest in 12 equal monthly installments starting June 12, 2026, conditioned on her continued service to the company.
What are the terms of the TRAX restricted stock units granted to Rita Jain?
She was granted 2,500 restricted stock units, each representing a right to receive one share of common stock for no cash payment. All RSUs vest 100% on the date of First Tracks Biotherapeutics’ 2027 annual shareholder meeting, subject to her continued service.
When do Rita Jain’s newly granted TRAX stock options vest and expire?
The stock options vest as to one-twelfth of the 7,000 shares each month, beginning June 12, 2026, until fully vested. The options expire on May 11, 2036, if not exercised, according to the disclosure details.
Does the Form 4/A for TRAX show any stock sales or purchases by Rita Jain?
The filing shows no open-market buying or selling. It only reports equity compensation awards: a grant of stock options and a grant of restricted stock units, both classified as acquisitions under grant or award transactions, rather than market trades.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates